According to CNN, most countries in the Asia-Pacific region are rushing to order an antiviral drug called Molnupiravir even though this drug has not been licensed for use. Covid-19 drugs of the US Department of Vaccine deployment, many countries in the Asia-Pacific region are slower than countries like the United States and the United Kingdom. However, at the present time, they seem to be doing their best to avoid similar mistakes. Illustration. Source: CNNMolNupiravir - The drug produced by the US Merck Pharmaceutical Company, is expected to bring hope to humans in the fight against Covid-19 epidemic, especially with non-vaccinated objects
. MERCK has now submitted to the US Food and Drug Administration to apply for emergency use permits. If licensed, this capsule will become the first Covid-19 treatment drug. According to Airfinity Analysis Company, at least 8 countries and territories in the Asia-Thai Binh area signed Conclusion Agreements and are negotiating to buy this medicine, including New Zealand, Autralia and South Korea
Before that, all three countries were evaluated to deploy the immunization program for the domestic people. The experts said that the new US drug could be a pandemic change factor, especially with Those who cannot inject vaccines. However, many people have thought of using it as an alternative drug for CNN Vaccine.Theo CNN, the racing reserve tablets such as Molnupiravir in many Asian countries that can repeat the reserve reserve dynamics. As last year in some developed countries. "Molnupiravir is really a potential drug that changes the game. However, we should not repeat the move like the vaccine reserve," said Rachel Cohen - Executive Director The non-profit organization Drugs for Neglected Diseases Initiative indicates.The medical experts said, Molnupiravir was considered the latest anti-Covid-19 weapon by the flexible Covid-19 treatment, helping patients without need Hospital treatment must be hospitalized. If the patient has a Covid-19 disease, they can start treating with molnupiravir drugs. "Unlike the vaccine to create immunity, Molnupiravir has the effect of inhibiting the virus," Sanjaya Senanayake - infectious disease doctor and is Associate Professor of Medicine at the Australian National University said
Wendy Holman, CEO of Ridgeback Biotherapeutics Company confirmed in a very encouraging statement, test results and hope this medicine has Can bring the opportunity in the effort to control epidemics. "The antiviral treatment methods can be done at home to support patients with Covid-19 is essential," said Wendy Holman affirmed. Treating Covid - 19 What does it mean for vaccines? Experts still affirmed that no drugs can replace the vaccine. Vaccine is still the best protection method that reduces the risk of Covid-19. Currently, the vaccination rate in some Asia-Pacific countries has improved after slow start. However, millions of people still cannot vaccinate because they are not eligible or cannot access the injections. Therefore, Covid-19 drugs were born in order to support unqualified cases of vaccination.Nial Wheate, Associate Professor of Pharmacy of Sydney University, said that this drug will be a leading solution for many people. Cannot participate in vaccination. However, Mr. Wheate and other professionals also expressed anxiety, the introduction of this medicine can cause many people to be afraid to vaccinate, increasing the hesitation rate for vaccines in some countries, in which There are Australia. "Research shows that people prefer to take medicine rather than vaccination vaccines, Mr. Wheate said.Theo Data of Airfinity, currently has 10 countries and territories in the area negotiating or signed. Agreement to buy Molnupiravir, including 8 countries and territories in the Asia-Pacific region.Merck has not yet confirmed the price list for Molnupiravir because it has not been licensed for use. Dad in June, Merck said there will be a plan to use a different country's price approach and will sign licensing agreements with producers. pink . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
